Healthy volunteers test new MDS drug LP-001 for safety
NCT ID NCT06294275
First seen Jan 07, 2026 · Last updated May 16, 2026 · Updated 19 times
Summary
This early-stage study tested LP-001 in 68 healthy adults aged 18-50 to see if it is safe and how the body handles it. The drug is being developed for myelodysplastic syndrome (MDS), a blood disorder. The study gave single and multiple doses to gather key information before testing in patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROME (MDS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai Public Health Clinical Center
Shanghai, China
Conditions
Explore the condition pages connected to this study.